A Phase 1 Pharmacokinetic-pharmacodynamic Study Of Avelumab (msb0010718c) In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2016
At a glance
- Drugs Avelumab (Primary)
- Indications Hodgkin's disease
- Focus Pharmacokinetics
- Acronyms JAVELIN HODGKINS
- Sponsors Pfizer
- 07 Jun 2017 Biomarkers information updated
- 29 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 21 Mar 2016 Planned initiation date changed from 1 Feb 2016 to 1 Mar 2016, according to ClinicalTrials.gov record.